Back to search
Kidney Transplantation, Cytomegalovirus Infections
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Kidney Transplantation, Cytomegalovirus Infections trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Kidney Transplantation, Cytomegalovirus Infections trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study is designed to assess how effective letermovir is in preventing recurrence of cytomegalovirus (CMV) infection in adult kidney or kidney/pancreas tran…
Cytomegalovirus (CMV) establishes a chronic infection in 60% of the general population. In renal transplant recipients, it is responsible for morbidities occurr…
The purpose of this study is to evaluate the efficacy and the tolerance of letermovir as part of dual antiviral therapy (in association with valganciclovir) in…
This study is being done to find out if administering CytoGam® after the end of standardly prescribed preventive antiviral treatment can help transplant recipie…
Opportunistic CMV viremia (primary infection or reactivation) is usually managed by taking prophylactic medication for both adult and pediatric kidney transplan…
The main aim of this study is to assess the safety of maribavir in adults with severe CKD or comorbid ESRD including participants on artificial filtering of the…
CMV infection in transplantation remains the most frequent infectious complication causing increased morbidity and mortality. International recommendations advo…
In kidney transplant patients, CMV infection remains the leading infectious cause of morbidity and mortality. Clinical and virological relapses are common and a…